Jason Barbour Net Worth (Estimated)
CEO at Synkrino Biotherapeutics · YC S18
Quick answer
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026.
Jason Barbour is CEO at Synkrino Biotherapeutics (YC S18). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Bachelor's degree from the University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 2
- Website: http://www.synkrino.bio
Who is Jason Barbour?
Jason Barbour is a co-founder of Synkrino Biotherapeutics, a company associated with Y Combinator from the summer of 2018.
Highlights:
- University of California, Berkeley
- Y Combinator S18
- Biotechnology entrepreneur
About Synkrino Biotherapeutics
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
Model inputs
- Stage: seed
- Valuation tier: raise-10x
- Funding input: reported raise $120K
- Research as-of: 2026-08-04
- Funding source: https://www.ycombinator.com/companies/synkrino-biotherapeutics
FAQ: Jason Barbour net worth and Synkrino Biotherapeutics valuation
What is Jason Barbour's net worth?
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.
Jason Barbour net worth
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. This Jason Barbour net worth figure is estimated paper wealth, not a verified statement of assets.
How much is Jason Barbour worth?
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. How much Jason Barbour is worth here means estimated paper wealth from public company and role data — not financial advice.
How rich is Jason Barbour?
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. “How rich is Jason Barbour” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.
Jason Barbour fortune
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. This Jason Barbour fortune figure is estimated paper wealth only, not a verified statement of assets.
Jason Barbour equity value
Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. Jason Barbour equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.
What is Synkrino Biotherapeutics valuation?
Synkrino Biotherapeutics's estimated valuation on Entrepreneurial Check is $1.2M. Independent model output, not a verified appraisal or official mark.
What is Synkrino Biotherapeutics post-money valuation?
Synkrino Biotherapeutics's estimated valuation on Entrepreneurial Check is $1.2M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.
What is Synkrino Biotherapeutics CEO net worth?
Jason Barbour is listed as CEO at Synkrino Biotherapeutics. Jason Barbour's estimated net worth / paper wealth is $780K (range $546K–$1.2M) as of 2026. This Synkrino Biotherapeutics CEO net worth figure is an independent paper-wealth estimate, not verified net worth.
What is Synkrino Biotherapeutics funding?
Synkrino Biotherapeutics funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Synkrino Biotherapeutics raised is not a complete cap table — figures are estimates only.
How much did Synkrino Biotherapeutics raise?
How much Synkrino Biotherapeutics raised, when disclosed, informs the estimated Synkrino Biotherapeutics valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.
How much money did Synkrino Biotherapeutics raise?
How much money Synkrino Biotherapeutics raised, when a public figure is available, is a model input for the estimated Synkrino Biotherapeutics valuation on this profile. Estimates only — not a complete cap table.
What is Synkrino Biotherapeutics series funding?
Synkrino Biotherapeutics series funding, when a public raise is disclosed, informs the estimated Synkrino Biotherapeutics valuation here. Not a complete financing history.
What company is Jason Barbour building?
Jason Barbour is CEO at Synkrino Biotherapeutics, a Y Combinator-backed startup (batch S18).
What does Synkrino Biotherapeutics do?
Synkrino Biotherapeutics — Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
What YC batch is Jason Barbour from?
Jason Barbour is associated with Y Combinator batch S18.
Where did Jason Barbour go to school?
Public profiles associate Jason Barbour with Bachelor's degree from the University of California, Berkeley.
Where is Jason Barbour based?
Public directory data lists Jason Barbour's region as United States of America.
What industry is Jason Barbour in?
Jason Barbour is listed under Healthcare, Drug Discovery and Delivery.
How big is Synkrino Biotherapeutics?
Public data lists Synkrino Biotherapeutics's team size as 2.
What else is notable about Jason Barbour?
University of California, Berkeley.
Is Entrepreneurial Check affiliated with Y Combinator?
No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.